Company news

ANI Pharmaceuticals, Inc. news in 2023

ANI Pharmaceuticals, Inc.'s news releases, calls and decks from 2023, newest first.

View company

ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

November 21, 2023

ANI Pharmaceuticals Reports Record Third Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

November 7, 2023

ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8: 30 a.m. ET

October 24, 2023

ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares

October 1, 2023

ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

September 17, 2023

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP

September 11, 2023

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%

August 27, 2023

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

August 23, 2023

ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors

August 22, 2023

ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

August 8, 2023

ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8: 30 a.m. ET

July 30, 2023

ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference

May 21, 2023

ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

May 15, 2023

ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity

May 14, 2023

ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock

May 11, 2023

ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock

May 10, 2023

ANI Pharmaceuticals Reports Record First Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

May 7, 2023

ANI Pharmaceuticals to Discuss First Quarter 2023 Financial Results on May 8, 2023, at 8: 30 a.m. ET

April 26, 2023

ANI Pharmaceuticals to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

April 25, 2023

ANI Pharmaceuticals Announces the FDA Approval and Launch of Nitrofurantoin Oral Suspension USP

April 23, 2023

ANI Pharmaceuticals Announces the FDA Approval of Colestipol Hydrochloride Tablets USP

April 3, 2023

ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance

March 8, 2023

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8: 30 a.m. ET

February 21, 2023

Calls in 2023

Decks in 2023